Internal Medicine, Cardiovascular Disease · Cleveland, OH
NPI
1033128731
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
9500 Euclid Ave
Cleveland, OH, 44195
Phone (800) 223-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
642 services
Medicare patients, 2024
290
Average age 74
Drug cost, 2024
$20.9M
2,881 prescriptions
Company payments, 2025
$60K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mazen A Hanna was code 99214 (office e&m - established), 258 times for 165 patients. In total Mazen A Hanna billed 642 services in 27 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 258 | 165 | $68.23 | $18K |
| 99233 Hospital E&M - Subsequent | Facility | 67 | 26 | $89.70 | $6,010 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 50 | 50 | $12.24 | $612 |
| 99215 Office E&M - Established | Facility | 47 | 43 | $101.60 | $4,775 |
| 99204 Office E&M - New | Facility | 32 | 32 | $93.34 | $2,987 |
| 99214 Office E&M - Established | Office | 22 | 21 | $92.86 | $2,043 |
| 99205 Office E&M - New | Facility | 22 | 22 | $123.46 | $2,716 |
| 99421 Office/Outpatient Services | Facility | 22 | 19 | $9.23 | $203 |
| 99232 Hospital E&M - Subsequent | Facility | 19 | 12 | $59.71 | $1,134 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 13 | 13 | $21.78 | $283 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $121.22 | $1,333 |
By year: 2022 $6,628 for 96 services; 2023 $30K for 362 services; 2024 $45K for 642 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mazen A Hanna prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 740 prescriptions and refills. In total Mazen A Hanna wrote 2,881 Medicare prescriptions that cost $20.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyndamax Tafamidis | 740 | 822 | 89 | $18.2M |
| Spironolactone Generic | 305 | 834 | 106 | $1,705 |
| Jardiance Empagliflozin | 203 | 449 | 54 | $257K |
| Metoprolol Succinate Generic | 157 | 421 | 58 | $2,517 |
| Torsemide Generic | 147 | 421 | 64 | $4,052 |
| Eliquis Apixaban | 143 | 292 | 38 | $165K |
| Entresto Sacubitril/Valsartan | 117 | 237 | 40 | $154K |
| Vyndaqel Tafamidis Meglumine | 91 | 91 | 13 | $2.0M |
| Atorvastatin Calcium Generic | 82 | 221 | 31 | $886 |
| Digoxin Generic | 80 | 202 | 23 | $1,025 |
| Carvedilol Generic | 77 | 206 | 29 | $542 |
| Eplerenone Generic | 66 | 184 | 26 | $5,864 |
| Farxiga Dapagliflozin Propanediol | 63 | 147 | 25 | $81K |
| Lisinopril Generic | 49 | 147 | 17 | $306 |
| Amlodipine Besylate Generic | 45 | 123 | 18 | $237 |
Brand drugs: - claims; generic drugs: 1,457 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mazen A Hanna $60K ($47K in general payments such as food, travel and fees and $13K for research) from 12 companies. The largest payer was Pfizer Inc. with $25K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 20 | $25K |
| Alnylam Pharmaceuticals Inc. ALNY | 11 | $18K |
| Alexion Pharmaceuticals, Inc. AZN | 9 | $13K |
| AstraZeneca UK Limited AZN | 3 | $2,003 |
| CVRx, Inc. CVRX | 1 | $169 |
| BridgeBio Pharma, Inc. BBIO | 1 | $143 |
| Abiomed JNJ | 1 | $127 |
| Scpharmaceuticals Inc. SCPH | 1 | $115 |
| Abbott Laboratories ABT | 1 | $90.28 |
| Impulse Dynamics (USA) Inc. | 1 | $27.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.